BioCentury
ARTICLE | Company News

Cytel other research news

May 17, 1999 7:00 AM UTC

CYTL's Epimmune Inc. subsidiary received a five-year $2.25 million grant from the National Institute of Allergy and Infectious Diseases to develop epitope-based vaccines using Epimmune's EIS, which a...